Comments
Loading...

Avadel Pharmaceuticals

AVDLNASDAQ
Logo brought to you by Benzinga Data
$13.60
-0.05-0.37%
At Close: -
$13.60
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$29.00
Lowest Price Target1
$11.00
Consensus Price Target1
$21.00

Avadel Pharmaceuticals (NASDAQ:AVDL) Stock, Analyst Ratings, Price Targets, Forecasts

Avadel Pharmaceuticals PLC has a consensus price target of $21 based on the ratings of 10 analysts. The high is $29 issued by Oppenheimer on March 5, 2024. The low is $11 issued by Jefferies on November 30, 2022. The 3 most-recent analyst ratings were released by Needham, Needham, and HC Wainwright & Co. on September 4, 2024, August 29, 2024, and August 28, 2024, respectively. With an average price target of $23.67 between Needham, Needham, and HC Wainwright & Co., there's an implied 74.02% upside for Avadel Pharmaceuticals PLC from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
HC Wainwright & Co.
Craig-Hallum
Piper Sandler
Oppenheimer

1calculated from analyst ratings

Analyst Ratings for Avadel Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Avadel Pharmaceuticals (AVDL) stock?

A

The latest price target for Avadel Pharmaceuticals (NASDAQ:AVDL) was reported by Needham on September 4, 2024. The analyst firm set a price target for $22.00 expecting AVDL to rise to within 12 months (a possible 61.76% upside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Avadel Pharmaceuticals (AVDL)?

A

The latest analyst rating for Avadel Pharmaceuticals (NASDAQ:AVDL) was provided by Needham, and Avadel Pharmaceuticals reiterated their buy rating.

Q

When was the last upgrade for Avadel Pharmaceuticals (AVDL)?

A

The last upgrade for Avadel Pharmaceuticals PLC happened on November 30, 2022 when Jefferies raised their price target to $11. Jefferies previously had a hold for Avadel Pharmaceuticals PLC.

Q

When was the last downgrade for Avadel Pharmaceuticals (AVDL)?

A

The last downgrade for Avadel Pharmaceuticals PLC happened on August 10, 2022 when Jefferies changed their price target from $6 to $8 for Avadel Pharmaceuticals PLC.

Q

When is the next analyst rating going to be posted or updated for Avadel Pharmaceuticals (AVDL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Avadel Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Avadel Pharmaceuticals was filed on September 4, 2024 so you should expect the next rating to be made available sometime around September 4, 2025.

Q

Is the Analyst Rating Avadel Pharmaceuticals (AVDL) correct?

A

While ratings are subjective and will change, the latest Avadel Pharmaceuticals (AVDL) rating was a reiterated with a price target of $22.00 to $22.00. The current price Avadel Pharmaceuticals (AVDL) is trading at is $13.60, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.